Project Grant R01MH132079
Award Date 8/1/26
Completion Date 4/30/31
Dollars Obligated $756K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
- The National Institute of Mental Health awarded Rhode Island Hospital $855,638 on August 20, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid Type I trial examining the effectiveness of ED_REACH, a family navigation intervention for youth discharged from emergency departments following suicide or non-suicidal self-injurious behavior evaluations. The trial will test ED_REACH (Resilience, Education, and Caregiver Help) with youth and their caregivers,...
- The National Institute of Mental Health awarded Butler Hospital $165,987 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop evidence-based suicide risk management protocols for research involving high-risk populations. The SAFER (Structuring Appropriate and Feasible Evaluations of Risk) project will create and evaluate protocols that balance participant safety with scientific validity in suicide risk research. The study pursues three aims: examining...
- The National Institute of Mental Health awarded Butler Hospital $781,566 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop RESTEPS, a suicide prevention intervention for youth with first-episode psychosis transitioning from acute care to outpatient treatment. The study addresses a critical gap: youth with first-episode psychosis face elevated suicide risk during care transitions, yet clinical trials of suicide-focused interventions routinely exclude...
- The National Institute of Mental Health awarded Emma Pendleton Bradley Hospital $398,669 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the relationship between sleep disruption and psychosis-spectrum symptoms in adolescents aged 14–17 years. The research addresses three mechanistic gaps in the literature: the absence of dense sampling across days to measure temporal fluctuations between psychosis-spectrum symptoms and sleep in youth; reliance on...
- The Substance Abuse and Mental Health Services Administration awarded the State of Rhode Island Department of Health $735,000 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to implement BRIDGE RI, a statewide youth suicide prevention initiative. RIDOH's Violence and Injury Prevention Program will strengthen Rhode Island's youth suicide prevention infrastructure by improving early identification,...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the Rhode Island Department of Children, Youth and Families $2,997,022 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances (SED) program (CFDA 93.104). The recipient will establish a statewide behavioral health system of care for children and youth ages 6–21 with or at risk for serious emotional disturbance by...
- The National Institutes of Health Office of the Director awarded Women & Infants Hospital of Rhode Island $875,534 on July 6, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to study subclinical deficits in attention, executive function, and social communication in children born very preterm. The project will recruit and follow a cohort of 240 very preterm children (born before 32 weeks gestation) from the hospital's neonatal follow-up program, tracking them from ages 3...
- The Substance Abuse and Mental Health Services Administration awarded the Rhode Island Department of Children, Youth and Families (DCYF) $750,000 on September 30, 2026, through the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532). DCYF will strengthen and expand Rhode Island's statewide mobile response and stabilization services (MRSS) system by enhancing geographic reach, workforce capacity, and programmatic infrastructure. The project...
- The National Institute of Mental Health awarded Emma Pendleton Bradley Hospital $737,000 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate mitochondrial signaling, stress, and sleep in children with internalizing disorders. The study quantifies cell-free mitochondrial DNA (CF-mtDNA) as a biomarker of stress-induced physiological changes in pediatric mental health. The research recruits 60 children ages 9–12 with internalizing disorders from a day...
- The National Institute of Mental Health awarded Research Foundation For Mental Hygiene, Inc. (operating as New York State Psychiatric Institute) $868,015 on June 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support a project titled "SAFER: Suicide Assessment and Follow-Up After Emergency Department Release for 8-12-Year-Old Children." The award funds the development and implementation of suicide assessment and follow-up protocols for elementary school-aged...